Ms. Bavani Shankar has over 18 years experience in the pharmaceutical industry and 10 years of experience in the management of clinical projects, manufacturing projects, partner alliances and strategic projects. To date, she has managed one Phase-III trial, 6 Phase-II trials and several Phase-I trials.

Ms. Bavani Shankar is the primary person responsible for managing all projects related to eltoprazine at PsychoGenics using external resources such as Contract Research Organizations (CROs), consulting agencies and/or clinical sites, including an additional Phase-II proof-of-concept trial for treatment of cognitive impairment.